Kunwei W. Shen
197 Ruijin Second Road
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 174 publications
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 26, 2026
Cancer-associated adipocytes confer CDK4/6 inhibitor resistance in ER+ breast cancer through an IL-6/STAT3/SREBF2 axis coupled with cholesterol metabolism and cell cycle reprogramming.
Journal: International journal of biological sciences
Published: December 28, 2025
Omitting axillary lymph node dissection or not? A multicenter, retrospective study for breast cancer patients potentially eligible for abemaciclib since the SENOMAC trial.
Journal: World journal of surgical oncology
Published: December 15, 2025
Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 09, 2025
Associations of TILs and Genomic Alterations in HER2+ Early Breast Cancer.
Journal: Endocrine-related cancer
Published: October 15, 2025
Microenvironmental regulation and remodeling of breast cancer angiogenesis: from basic mechanisms to clinical therapeutic implications.
Journal: Discover oncology
Published: August 12, 2025
Integrating genomic mutations and tumor-infiltrating lymphocytes improves prediction of response to trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: July 03, 2025
Distribution and molecular drivers of the 21-gene recurrence score in early breast cancer with low, intermediate, and high estrogen receptor expression.
Journal: Frontiers in immunology
Published: June 25, 2025
Anthracycline-Free Neoadjuvant Therapy With Nab-Paclitaxel and Carboplatin in Non-Luminal Breast Cancer: A Single-Arm Clinical Trial.
Journal: International journal of cancer
Published: June 10, 2025
Clinicopathological and molecular significance of HER2-low expression in Asian women with triple-negative breast cancer.
Journal: Therapeutic advances in medical oncology
Published: February 25, 2025
Preoperative magnetic resonance imaging evaluation improves breast conserving surgery rate but not local disease control in patients with ductal carcinoma in situ.
Journal: European journal of radiology
Published: February 14, 2025
Last Updated: 09/26/2026